ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
708 Side effects of BCG in the treatment of intermediate and high risk Ta T1 papillary carcinoma of the bladder: Results from EORTC GU Cancers Group randomized study 30962 comparing 1/3 dose vs full dose during 1 or 3 years
European Urology Supplements
◽
10.1016/s1569-9056(13)61190-2
◽
2013
◽
Vol 12
(1)
◽
pp. e708
Author(s):
M. Brausi
◽
J. Oddens
◽
R. Sylvester
◽
S. Colette
◽
P. Gontero
◽
...
Keyword(s):
Side Effects
◽
High Risk
◽
Papillary Carcinoma
◽
Randomized Study
◽
Full Dose
◽
Carcinoma Of The Bladder
Download Full-text
Related Documents
Cited By
References
1694 SIDE EFFECTS OF BCG IN THE TREATMENT OF INTERMEDIATE AND HIGH RISK TA T1 PAPILLARY CARCINOMA OF THE BLADDER: RESULTS FROM EORTC GU CANCERS GROUP RANDOMIZED STUDY 30962 COMPARING 1/3 DOSE VS FULL DOSE DURING 1 OR 3 YEARS
The Journal of Urology
◽
10.1016/j.juro.2013.02.3004
◽
2013
◽
Vol 189
(4S)
◽
Author(s):
Maurizio Brausi
◽
Jorg Oddens
◽
Richard Sylvester
◽
Aldo Bono
◽
Paolo Gontero
◽
...
Keyword(s):
Side Effects
◽
High Risk
◽
Papillary Carcinoma
◽
Randomized Study
◽
Full Dose
◽
Carcinoma Of The Bladder
Download Full-text
Re: Side Effects of bacillus Calmette-Guérin (BCG) in the Treatment of Intermediate- and High-Risk Ta, T1 Papillary Carcinoma of the Bladder: Results of the EORTC Genito-Urinary Cancers Group Randomised Phase 3 Study Comparing One-Third Dose with Full Dose and 1 Year with 3 Years of Maintenance BCG
The Journal of Urology
◽
10.1016/j.juro.2014.09.034
◽
2014
◽
Vol 192
(6)
◽
pp. 1641-1641
Author(s):
David P. Wood
Keyword(s):
Side Effects
◽
High Risk
◽
Papillary Carcinoma
◽
Bacillus Calmette Guerin
◽
Phase 3
◽
Full Dose
◽
Carcinoma Of The Bladder
Download Full-text
Side Effects of Bacillus Calmette-Guérin (BCG) in the Treatment of Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Bladder: Results of the EORTC Genito-Urinary Cancers Group Randomised Phase 3 Study Comparing One-third Dose with Full Dose and 1 Year with 3 Years of Maintenance BCG
European Urology
◽
10.1016/j.eururo.2013.07.021
◽
2014
◽
Vol 65
(1)
◽
pp. 69-76
◽
Cited By ~ 122
Author(s):
Maurizio Brausi
◽
Jorg Oddens
◽
Richard Sylvester
◽
Aldo Bono
◽
Cees van de Beek
◽
...
Keyword(s):
Side Effects
◽
High Risk
◽
Papillary Carcinoma
◽
Bacillus Calmette Guerin
◽
Phase 3
◽
Full Dose
◽
Carcinoma Of The Bladder
Download Full-text
Faculty Opinions recommendation of Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717964808.793498086
◽
2014
◽
Author(s):
Alexander Bachmann
◽
Jan Ebbing
Keyword(s):
High Risk
◽
Urinary Bladder
◽
Papillary Carcinoma
◽
Randomized Study
◽
Bacillus Calmette Guerin
◽
Full Dose
Download Full-text
Faculty Opinions recommendation of Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717964808.793466279
◽
2012
◽
Author(s):
Mark Gonzalgo
Keyword(s):
High Risk
◽
Urinary Bladder
◽
Papillary Carcinoma
◽
Randomized Study
◽
Bacillus Calmette Guerin
◽
Full Dose
Download Full-text
Faculty Opinions recommendation of Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717964808.793475577
◽
2013
◽
Author(s):
Evangelos Liatsikos
◽
Panagiotis Kallidonis
Keyword(s):
High Risk
◽
Urinary Bladder
◽
Papillary Carcinoma
◽
Randomized Study
◽
Bacillus Calmette Guerin
◽
Full Dose
Download Full-text
Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance
European Urology
◽
10.1016/j.eururo.2012.10.039
◽
2013
◽
Vol 63
(3)
◽
pp. 462-472
◽
Cited By ~ 221
Author(s):
Jorg Oddens
◽
Maurizio Brausi
◽
Richard Sylvester
◽
Aldo Bono
◽
Cees van de Beek
◽
...
Keyword(s):
High Risk
◽
Urinary Bladder
◽
Papillary Carcinoma
◽
Randomized Study
◽
Bacillus Calmette Guerin
◽
Full Dose
Download Full-text
Re: Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance
European Urology
◽
10.1016/j.eururo.2013.04.027
◽
2013
◽
Vol 64
(1)
◽
pp. 171-172
Author(s):
Brant A. Inman
Keyword(s):
High Risk
◽
Urinary Bladder
◽
Papillary Carcinoma
◽
Randomized Study
◽
Bacillus Calmette Guerin
◽
Full Dose
Download Full-text
Re: Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance
European Urology
◽
10.1016/j.eururo.2013.12.034
◽
2014
◽
Vol 65
(4)
◽
pp. 847-848
◽
Cited By ~ 2
Author(s):
Eduardo Solsona
Keyword(s):
High Risk
◽
Urinary Bladder
◽
Papillary Carcinoma
◽
Randomized Study
◽
Bacillus Calmette Guerin
◽
Full Dose
Download Full-text
Re: Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-Risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-Third Dose versus Full Dose and 1 Year versus 3 Years of Maintenance
The Journal of Urology
◽
10.1016/j.juro.2013.10.133
◽
2014
◽
Vol 191
(2)
◽
pp. 348-349
Author(s):
David P. Wood
Keyword(s):
High Risk
◽
Urinary Bladder
◽
Papillary Carcinoma
◽
Randomized Study
◽
Bacillus Calmette Guerin
◽
Full Dose
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close